Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Myc Mutations and Cancer

Cancer Pain

Cancer History

What Role do Biobanks Play in Cancer Research?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Investigating the Molecular Mechanisms of Cancer

What is Cancer?

What Causes Cancer?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Diagnosis

What is Tumorigenesis?

See more featured articles »

Cancer Screening Considerations: Balancing the Benefits and Risks

What is the Tumor Microenvironment?

Cancer Pain Management

Cancer Research

Assay for Monitoring and Treating Malignant Brain Tumors

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Is Cancer a Metabolic Disorder?

British Pioneers in Cancer Biology

Insight into Cancer Vaccines

Cancer Prevention: Lowering your Risk

Cancer Glossary

Cancer Symptoms

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Pathophysiology

Secondary Lung Cancer

Transforming Cancer Care through Genomic Testing

Targeted Cancer Therapies

The Cancer Cell Surface Proteome as a Therapeutic Target

Living with Cancer Pain

Cancer Management

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

What is Cancer of Unknown Primary?

Hypoxia Markers and Their Importance

Insights into Oncofertility

The Biochemistry of Breast Cancer Screening

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cutaneous Manifestations of Internal Malignancy

Overview of Cell Viability and Cytotoxicity

CDK9 and Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Why are Cancer Cell Lines Useful?

Acidosis and Tumor Progression

Pediatric Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Microfluidic cancer treatment screen combined with flow cytometry

Secondary Brain Cancer

Cancer Prognosis

Effects of Social and Economic Deprivation on Cancer Mortality

Caring for a Loved One with Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

The Effects of Cancer on Family Life

TARDIS: The Improved Method of Detecting Breast Cancer

What is Immunochemotherapy?

Cancer Classification

Using Biomarkers to Detect Cancer

Hot vs Cold: the differences between tumor types

Metastatic Migration in Cancer may be Influenced by Metabolism

What is Merkel Cell Carcinoma?

Cancer Epidemiology

Extracellular Vesicles as Floating Cancer Biomarkers

Latest Cancer News and Research

UMass Amherst researcher wins $2.5 million to expand nanoparticle cancer vaccine study

Having established the effectiveness of her nanoparticle drug-delivery system for cancer immunotherapy, University of Massachusetts Amherst researcher Prabhani Atukorale, has been awarded $2.5 million from the National Institutes of Health to broaden the scope of her vaccine research to include treating those with active cancer.

27 Aug 2026

New mutant rat model replicates human chronic kidney disease

Chronic kidney disease (CKD) is a major health burden affecting approximately one in ten adults globally. Even with improved treatments, many patients continue to have worsening loss of kidney function, resulting in the need for dialysis or transplantation.

27 Aug 2026

Fleeting interactions between membrane sugar chains control cell division

Acting as an armor, a scaffold, and a communication platform in one, our cells' plasma membrane lies at the heart of many crucial cellular processes.

27 Aug 2026

Study challenges traditional breast cancer classification methods

Breast cancer is often classified as either estrogen receptor-positive (hormone-sensitive) or not. However, a new study from Karolinska Institutet suggests that this simplified classification may overlook important biological differences between patients that could affect treatment decisions.

27 Aug 2026

New funding backs pioneering research to make brain cancer treatment more effective

Adelaide researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

27 Aug 2026

UofL receives new federal funding to advance metabolic health research

Chronic health conditions such as diabetes, obesity, heart disease and metabolic liver disease have sharply increased in recent decades and are among the most urgent health challenges facing our society.

27 Aug 2026

Computer model could streamline design of protein degraders

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.

27 Aug 2026

Study reveals why diffuse midline glioma develops in brain midline regions

Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to the H3.3 K27M, a mutation in the histone H3.3 protein that drives many cases of diffuse midline glioma (DMG), depending on the cell's location in the developing brain.

27 Aug 2026

FDA approves first RAS-targeted therapy for metastatic pancreatic cancer

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

27 Aug 2026

New study tracks global colorectal cancer risk across 185 nations

Colorectal cancer has long been recognized as a major global health threat, but its burden is far from evenly distributed. Incidence and mortality rates vary dramatically across countries, and these differences are closely tied to socioeconomic development, dietary transitions, and the adoption of screening programs.

26 Aug 2026

New review examines oral cancer drug delivery barriers and strategies

Delivering drugs directly to oral tumor sites remains challenging. A recent review involving researchers from Hasanuddin University examines barriers to local drug delivery and analyses strategies for targeting oral cancer lesions.

26 Aug 2026

Real-world Chinese study confirms benefits of niraparib maintenance therapy for ovarian cancer

Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with a high risk of recurrence even after successful initial treatment.

26 Aug 2026

Artificial sweetener xylitol associated with higher risk of adverse cardiovascular events

A study to be presented at ESC Congress 2026 will show that high blood levels of the artificial sweetener, xylitol, were associated with increased risk of major adverse cardiovascular events.

26 Aug 2026

Study links finasteride to fewer complications after heart attack in men

Patients treated with medication for benign prostatic hyperplasia at the time of a severe acute heart attack experienced fewer serious complications from the attack, according to a study from the University of Gothenburg.

26 Aug 2026

New grants support biotechnology and cancer research projects at KIT

In its CZS Nexus program, the Carl Zeiss Foundation has awarded grants to two young scientists from the Karlsruhe Institute of Technology (KIT). The researchers will each receive EUR 1.5 million to establish their own interdisciplinary working groups at KIT.

26 Aug 2026